doxantrazole has been researched along with Allodynia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agostini, S; Broccardo, M; Bueno, L; Cartier, C; Eutamene, H; Ferrier, L; Houdeau, E; Improta, G; Petrella, C; Theodorou, V | 1 |
Ait-Belgnaoui, A; Bueno, L; Eutamène, H; Fioramonti, J; Garcia-Villar, R; Róka, R; Salvador-Cartier, C | 1 |
2 other study(ies) available for doxantrazole and Allodynia
Article | Year |
---|---|
Evidence of central and peripheral sensitization in a rat model of narcotic bowel-like syndrome.
Topics: Abdominal Pain; Animals; CD11b Antigen; Chymases; Colon; Delayed-Action Preparations; Disease Models, Animal; Gastrointestinal Transit; Hyperalgesia; Immunohistochemistry; Intestinal Mucosa; Male; Mast Cells; Microglia; Minocycline; Morphine; Naltrexone; Narcotic Antagonists; p38 Mitogen-Activated Protein Kinases; Pain Measurement; Pain Threshold; Pressure; Rats; Rats, Wistar; Spinal Cord; Syndrome; Thioxanthenes; Time Factors; Ubiquitin Thiolesterase; Xanthones | 2010 |
Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats.
Topics: Animals; Cell Count; Colon; Dexamethasone; Glucocorticoids; Hyperalgesia; Immunohistochemistry; Infusions, Parenteral; Injections, Intraperitoneal; Intestinal Mucosa; Male; Mast Cells; Metalloendopeptidases; Oligopeptides; Permeability; Rats; Rats, Wistar; Receptor, PAR-2; Thioxanthenes; Viscera; Xanthones | 2007 |